Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Black Mamba
View:
Post by GunnerG on Feb 17, 2022 7:13pm

Black Mamba

In case you are wondering...CLICK HERE FOR REPORT

Comment by stockbuphoon on Feb 17, 2022 7:30pm
we should have GunnerG investigated as part of the great short as he joined PLI board and said he and his wife invested but he's still here bashing (which is understandable at this time as thomvest is in 100% control) and bashing anyone who was fooled and lost their shirt. Really nice guy.  
Comment by PLIImfoservice on Feb 20, 2022 2:42am
I remember texting PL regarding  Black Mamba if I was not mistaken he was on a plane coming home from New York  I was Skyhigh123 back then 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities